Dr. Song’s research is focused on developing safer and more efficient AAV vectors for liver-target gene therapy. He is working on the evaluation of hepatotoxicity risks in 3D spheroids models for AAV gene therapy.

Animal Models, Gene Editing, Primary Cell Culture, Stem cell differentiation, Systems Biology, Translation Research Blood-brain Barrier, Cancer, Disease Models, Drug Delivery, Drug Discovery, Gene Therapy, Glioblastoma, Nanoparticle, Neuroengineering, Oncology, Rare Diseases, Stem Cells